Congressman’s Ties To Foreign Biotech Draw Criticism

KHN Original

Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.

At Party Retreat, GOP Still Searching For Health Law Consensus

KHN Original

At their party retreat, the officials are coalescing around a strategy that would have not a single replacement for the Affordable Care Act but instead include changes through a budget bill, administrative action and later a series of individual bills addressing smaller aspects of the health system.